Ob/Gyn Articles

Ob/Gyn

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mullins CD et al. – As pharmacoeconomic evaluations for coverage decisions made by US public programs grows, the need for precise and consistent estimation of drug costs is warranted. Application of the proposed recommendations will allow researchers to include accurate and unbiased cost estimates in pharmacoeconomic evaluations.

Related Articles

Medicare Spending for Previously Uninsured Adults
Annals of Internal Medicine, 10/13/09    Relevance Score: 94%

CMS announces Medicare premiums, deductibles for 2010
American Hospital Association News, 11/13/09    Relevance Score: 93%

Cms proposes new rules for medicare advantage and prescription drug plans to better serve beneficiaries
Centers for Medicare & Medicaid Services Press, 10/26/09    Relevance Score: 91%

Medicare pricing gets new look; RUC process revisited
American Medical News, 10/23/09    Relevance Score: 91%

CMS will hold town hall meeting on Sec. 935 appeals
American Hospital Association News, 10/14/09    Relevance Score: 91%

Today in Economics of Medicine...keeping you current

"Better Ways to Pay for Health Care", Recommended by National Health Care Quality Coalition
AMN Healthcare, 11/25/09

Stimulating EMR adoption
American Medical News , 11/25/09

Rising mortality and life expectancy differentials by lifetime earnings in the United States
Journal of Health Economics, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address